1,957
Views
0
CrossRef citations to date
0
Altmetric
Review Article

A systematic review and meta-analysis of efficacy and safety of compound glycyrrhizin combined with second-generation non-sedated antihistamine for the treatment of chronic urticaria

, , , , , , & show all
Article: 2299597 | Received 20 Nov 2023, Accepted 20 Dec 2023, Published online: 03 Jan 2024

References

  • Saini S, Shams M, Bernstein JA, et al. Urticaria and angioedema across the ages. J Allergy Clin Immunol Pract. 2020;8(6):1–18. doi: 10.1016/j.jaip.2020.03.030.
  • Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734–766. doi: 10.1111/all.15090.
  • Corral-Magaña O, Gil-Sánchez JA, Bover-Bauzá C, et al. Chronic urticaria in children under 15 years of age: clinical experience beyond the clinical trials. Pediatr Dermatol. 2021;38(2):385–389. doi: 10.1111/pde.14455.
  • He L, Yi W, Huang X, et al. Chronic urticaria: advances in understanding of the disease and clinical management. Clin Rev Allergy Immunol. 2021;61(3):424–448. doi: 10.1007/s12016-021-08886-x.
  • Fricke J, Ávila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy. 2020;75(2):423–432. doi: 10.1111/all.14037.
  • Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy. 2011;66(3):317–330. doi: 10.1111/j.1398-9995.2010.02496.x.
  • Vestergaard C, Deleuran M. Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy. Ther Adv Chronic Dis. 2015;6(6):304–313. doi: 10.1177/2040622315603951.
  • SáNCHEZ J, Amaya E, Acevedo A, et al. Prevalence of inducible urticaria in patients with chronic spontaneous urticaria: associated risk factors. J Allergy Clin Immunol Pract. 2017;5(2):464–470. doi: 10.1016/j.jaip.2016.09.029.
  • Zuberbier T, Aberer W, Asero R, et al. Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2014;69(7):e1-29–29. doi: 10.1111/all.12370.
  • Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73(7):1393–1414. doi: 10.1111/all.13397.
  • Cataldi M, Maurer M, Taglialatela M, et al. Cardiac safety of second-generation H(1) -antihistamines when updosed in chronic spontaneous urticaria. Clin Exp Allergy. 2019;49(12):1615–1623. doi: 10.1111/cea.13500.
  • Fuhrmann T, Smith N, Tausk F. Use of complementary and alternative medicine among adults with skin disease: updated results from a national survey. J Am Acad Dermatol. 2010;63(6):1000–1005. doi: 10.1016/j.jaad.2009.12.009.
  • Baron SE, Goodwin RG, Nicolau N, et al. Use of complementary medicine among outpatients with dermatologic conditions within yorkshire and South Wales, United Kingdom. J Am Acad Dermatol. 2005;52(4):589–594. doi: 10.1016/j.jaad.2004.11.058.
  • Smith N, Shin DB, Brauer JA, et al. Use of complementary and alternative medicine among adults with skin disease: results from a national survey. J Am Acad Dermatol. 2009;60(3):419–425. doi: 10.1016/j.jaad.2008.11.905.
  • Yu JJ, Zhang CS, Coyle ME, et al. Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials. Curr Med Res Opin. 2017;33(2):279–287. doi: 10.1080/03007995.2016.1254605.
  • VAN Rossum TG, Vulto AG, DE Man RA, et al. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther. 1998;12(3):199–205. doi: 10.1046/j.1365-2036.1998.00309.x.
  • Wang J, Yu S, Xiao W. Clinical application of compound glycyrrhizin (meineng) in liver disease [J]. China Pharmacy. 2002;08:52–54. (in Chinese).
  • Segal R, Pisanty S. Glycyrrhizin gel as a vehicle for idoxuridine–I. Clinical investigations. J Clin Pharm Ther. 1987;12(3):165–171. doi: 10.1111/j.1365-2710.1987.tb00522.x.
  • Khaksa G, Zolfaghari ME, Dehpour AR, et al. Anti-inflammatory and anti-nociceptive activity of disodium glycyrrhetinic acid hemiphthalate. Planta Med. 1996;62(4):326–328. doi: 10.1055/s-2006-957894.
  • Cheng Zhuhai DSCT. Pharmacokinetics and clinical application of compound glycyrrhizin. Chinese J Modern Appl Pharm. 2005;22(0z3):830–832. (in Chinese).
  • Cao W, Xiao X, Zhang L, et al. Compound glycyrrhizin combined with antihistamines for chronic urticaria: a protocol for systematic review and meta analysis. Medicine (Baltimore). 2020;99(33):e21624.), doi: 10.1097/md.0000000000021624.
  • Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1–9. doi: 10.1186/2046-4053-4-1.
  • URTICARIA RESEARCH CENTER D A V S C M A. Chinese guidelines for the diagnosis and treatment of urticaria 2018 ­edition. Chinese J Dermatol(Zhonghua Pifuke Zazhi). 2019;52(1):5. (in Chinese). doi: 10.3760/cma.j.issn.0412-4030.2019.01.001.
  • Shi CXG, Wang M, ET AL. Investigation on evaluation criteria of clinical efficacy of chronic urticaria in China. Chinese J Med Library Inform Sci. 2014;12:5. doi: 10.3969/j.issn.1671-3982.2014.12.011.
  • Cochrane handbook for systematic reviews of interventions. [M/OL]. 2014
  • Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10(10):Ed000142. doi: 10.1002/14651858.Ed000142.
  • Zhang J, Yang Y, Jiang G, et al. Observation of clinical efficiency of desloratadine combined with compound glycyrrhizin in the treatment of 66 patients with chronic urticaria. Chinese J Dermatovenereol. 2013;27(7):755–756. (in Chinese).
  • Zhao H, Peng X, Yang S. Effect observation of desloratadine combined compound glycyrrhizin in treatment of chronic urticaria. J Med Forum. 2011;32(7):53–55. (in Chinese).
  • Yang Yuming MP. Therapeutic effect of desloratadine plus compoud glycyrrhizin intreatment of chronic urticaria. Channel Pharmacy. 2008;20(10):100–101. (in Chinese).
  • Wang Shiming CY. Clinical observation of 30 cases of chronic urticaria treated by compound glycyrrhizin combined with desloratadine. J Zunyi Med Univ. 2007;118(01):58–59. (in Chinese).
  • Yongzhong W. Efficacy of compound glycyrrhizin combined with desloratadine in the treatment of chronic urticaria. J Diag Therapy Dermato-Venereolog. 2006;13(3):227–229. (in Chinese).
  • Yingzhu B. The treatment of compound glycyrrhizin combined with loratadine was slow clinical observation of sexual urticaria. Northwest Pharmaceut J. 2009;24(3):213–214. (in Chinese).
  • Xia Jianxin ZF, Yinghui CUI. Effect of compound glycyrrhizin combined with mizolastine in the treatment of chronic urticaria. Food and Drug. 2005;7(11):67–68. (in Chinese).
  • Jing W. Observation of clinical efficacy of compound glycyrrhizin combined with cetirizine in treatment of chronic urticaria. Med J Chinese People’s Health. 2014;26(21):76–77. (in Chinese).
  • Yang Yanlong JG, Jin Z. Effect of compound glycyrrhizin combined with fexofenadine hydrochloride on chronic urticaria. China J Leprosy Skin Dis. 2012;28(05):371. (in Chinese).
  • Jianhua P. Observation of curative effects on treating chronic urticaria with compound glycyrrhizin concomitant with cetirizine. Chinese J Med Guide. 2011;13(1):71–72. (in Chinese).
  • Zeng Zhaolin LJ, Huifang YANG, Xiaoying YE. Effect of compound glycyrrhizin combined with epistin hydrochloride on chronic urticaria. J China Prescrip Drug. 2013;11(6):41–42. (in Chinese).
  • Mengxia Y. Efficacy of compound glycyrrhizin combined with levoxitirizine hydrochloride tablets in the treatment of chronic urticaria. Modern Pract Med. 2012;25(2):181–182. (in Chinese).
  • Xia Z. Clinical observation of compound glycyrrhizin combined with levocetirizine dihydrochloride in treatment of chronic urticaria. Chinese Foreign Med Res. 2011;9(23):13–14. (in Chinese).
  • Mei Zhen YX, Jieping C. Clinical observation of compound glycyrrhizin combined with epistin in the treatment of chronic urticaria. Chinese J Clin Rational Drug Use. 2015;8(32):69–70. (in Chinese).
  • Jinru W. Effect analysis of compound glycyrrhizin combined with levoxitirizine in the treatment of chronic urticaria in children. Front Med. 2013;(25):219–220. (in Chinese).
  • Wang Lixia GC, Xiaoning Z. Effect of compound glycyrrhizin combined with levocetirizine in the treatment of chronic urticaria. Dermatol Venereol. 2009;31(1):28–37. (in Chinese).
  • Man LAY. The clinical observation of compound glycyrrhizin injection combined with mizolastine in treatment of chronic urticaria. Clin Misdiagnosis Mistherapy. 2011;24(11):19–21. (in Chinese).
  • Ye L. Efficacy of desloratadine citrate combined with compound glycyrrhizin in the treatment of chronic urticaria. Journal of Shaanxi University of Chinese Medicine. 2015;38(6):57–60. (in Chinese).
  • Minghui B. Clinical study of desloratadine citrate combined with compound glycyrrhizin in the treatment of chronic urticaria. China J Leprosy Skin Dis. 2016;32(9):546–566. (in Chinese).
  • Ying X. Therapeutic effect of meilone tablet combined with cetirizine hydrochloride on chronic urticaria. China J Leprosy Skin Dis. 2006;22(10):878–879. (in Chinese).
  • Jianguang X. Efficacy of mizolastine combined with compound glycyrrhizin in the treatment of chronic urticaria. China Pract Med. 2008;3(29):91–92. (in Chinese).
  • Zhang Yunying ZR, Zhao YE, Caixia TU. Effect of epistin hydrochloride combined with compound glycyrrhizin in the treatment of chronic urticaria. Chinese J Dermatovenereol Integ Trad Western Med. 2012;11(2):116. (in Chinese).
  • Jigao Q. Clinical observation of levoxitirizine hydrochloride capsule combined with compound glycyrrhizin in the treatment of chronic urticaria [J]. Chinese Aesthetic Med. 2011;20(5):285. (in Chinese). doi: 10.3969/j.issn.1008-6455.2011.z5.297.
  • Zhao Chunhua QX. Effect of epistin combined with compound glycyrrhizin on chronic urticaria. China Foreign Med Treat. 2008;28(10):125–174. (in Chinese).
  • Jin G, Jin LL, Jin BX. The rationale behind the four major anti-COVID-19 principles of chinese herbal medicine based on systems medicine. Acupunct Herb Med. 2021;1(2):90–98. doi: 10.1097/HM9.0000000000000019.
  • Rui Y, Yuan BC, Ma YS, et al. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm Biol. 2017;55(1):5–18. doi: 10.1080/13880209.2016.1225775.
  • Wen Y, Tang Y, Li M, et al. Efficiency and safety of desloratadine in combination with compound glycyrrhizin in the treatment of chronic urticaria: a meta-analysis and systematic review of randomised controlled trials. Pharm Biol. 2021;59(1):1276–1285. doi: 10.1080/13880209.2021.1973039.
  • Lu Tao ZK, Jin-Bo ZOU, Xiao-Lin1 DU, et al. Compound glycyrrhizic acid glycosides combine with cetirizine for chronic urticaria: a systematic review of efficacy and safety. Chinese J Dermatovenereol. 2013;27(11):1083–1087. (in Chinese).
  • Peng-Fei Z. Efficacy and safety of compound glycyrrhizin combined with levocetirizine in the treatment of chronic urticaria: a meta-analysis. Clin Medication J. 2022;20(2):60–66. (in Chinese).
  • Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.
  • Minozzi S, Cinquini M, Gianola S, et al. The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application. J Clin Epidemiol. 2020;126:37–44. doi: 10.1016/j.jclinepi.2020.06.015.
  • Schwingshackl L, Rüschemeyer G, Meerpohl JJ. [How to interpret the certainty of evidence based on GRADE (grading of recommendations, assessment, development and evaluation)] [J]. Urologe A. 2021;60(4):444–454. doi: 10.1007/s00120-021-01471-2.